DXCMDexcom
We are a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring, or CGM, systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians around the world. 10-K, Item 1
- Employees
- 11,100
- Headquarters
- San Diego, CA
- CEO
- Jacob Steven Leach
- Next results
- around Jan 11, 2027
Every trade in DXCM shares that directors, officers and 10% owners reported on Form 4 since May 14, 2026. Open-market buys and sales are the trades the insider chose to make; grants, option exercises and shares withheld for tax are part of pay.
| Date | Insider | Role | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| Oct 27, 2026 | Sadie Stern | EVP Chief People & Culture Off | Sale (10b5-1) | -2,565 | 78.62 | 202K | 120,913 |
| Oct 15, 2026 | Michael Jon Brown | EVP Chief Legal Compliance Off | Sale (10b5-1) | -1,700 | 85.48 | 145K | 98,185 |
| Sep 28, 2026 | Sadie Stern | EVP Chief People & Culture Off | Sale (10b5-1) | -2,565 | 86.15 | 221K | 123,478 |
| Sep 15, 2026 | Michael Jon Brown | EVP Chief Legal Compliance Off | Sale (10b5-1) | -1,700 | 84.04 | 143K | 99,885 |
| Sep 15, 2026 | Nicholas Augustinos (indirect) | Director | Sale (10b5-1) | -6,539 | 84.04 | 550K | 29,293 |
| Sep 14, 2026 | Nicholas Augustinos (indirect) | Director | Sale (10b5-1) | -1,550 | 84.02 | 130K | 35,832 |
| Sep 10, 2026 | Jereme M. Sylvain | EVP, Chief Financal Officer | Sale (10b5-1) | -3,638 | 83.27 | 303K | 146,828 |
| Aug 27, 2026 | Sadie Stern | EVP Chief People & Culture Off | Sale (10b5-1) | -2,565 | 88.37 | 227K | 126,043 |
| Aug 20, 2026 | Kevin R. Sayer | Executive Chair, Director | Sale (10b5-1) | -19,308 | 89.71 | 1.7M | 309,662 |
| Aug 20, 2026 | Kevin R. Sayer | Executive Chair, Director | Sale (10b5-1) | -7,351 | 90.78 | 667K | 302,311 |
| Aug 20, 2026 | Kevin R. Sayer | Executive Chair, Director | Sale (10b5-1) | -97 | 91.41 | 9K | 302,214 |
| Aug 14, 2026 | Michael Jon Brown | EVP Chief Legal Compliance Off | Sale (10b5-1) | -1,700 | 91.93 | 156K | 102,953 |
| Aug 12, 2026 | Bridgette P. Heller | Director | Sale (10b5-1) | -1,012 | 88.29 | 89K | 29,570 |
| Aug 3, 2026 | Mark G. Foletta (indirect) | Director | Sale (10b5-1) | -2,000 | 85.32 | 171K | 48,852 |
| Jul 31, 2026 | Mark G. Foletta (indirect) | Director | Sale (10b5-1) | -2,000 | 80.00 | 160K | 50,852 |
| Jul 20, 2026 | Kevin R. Sayer | Executive Chair, Director | Sale (10b5-1) | -26,756 | 76.32 | 2.0M | 328,970 |
| Jul 15, 2026 | Michael Jon Brown | EVP Chief Legal Compliance Off | Sale (10b5-1) | -1,700 | 74.42 | 127K | 104,653 |
| Jul 6, 2026 | Kevin R. Sayer | Executive Chair, Director | Sale (10b5-1) | -26,756 | 72.00 | 1.9M | 355,726 |
| Jun 15, 2026 | Mark G. Foletta (indirect) | Director | Sale (10b5-1) | -3,801 | 74.10 | 282K | 53,051 |
| Jun 15, 2026 | Mark G. Foletta (indirect) | Director | Sale (10b5-1) | -199 | 74.82 | 15K | 52,852 |
| Jun 15, 2026 | Michael Jon Brown | EVP Chief Legal Compliance Off | Sale (10b5-1) | -1,700 | 75.55 | 128K | 106,353 |
| Jun 4, 2026 | Jon Coleman | EVP, Chief Commercial Officer | Sale (10b5-1) | -4,911 | 74.13 | 364K | 95,450 |
| Jun 3, 2026 | Jon Coleman | EVP, Chief Commercial Officer | Sale (10b5-1) | -4,912 | 73.00 | 359K | 100,361 |
| May 21, 2026 | Kevin R. Sayer | Executive Chair, Director | Sale (10b5-1) | -26,759 | 72.00 | 1.9M | 382,482 |
| May 15, 2026 | Michael Jon Brown | EVP, Chief Legal Officer | Sale (10b5-1) | -1,700 | 59.91 | 102K | 109,504 |
From the Form 4s in SEC's filing index; each date links to the filing. The Insider selling plans tab shows planned sales (10b5-1 plans and Form 144).
Work on DXCM in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/DXCM/export.csv") into a cell.